Mansbach Harry H (CIK 1300615) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-10-30). Recent activity: Buy ETNB (50,000 shares), Sell ETNB (352,656 shares), Sell ETNB (7,680 shares), Sell ETNB (8,498 shares), Sell ETNB (1,050 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-10-30 | 89bio, Inc. (ETNB) | Chief Medical Officer | Buy | 50,000 | $0 |
| 2025-10-30 | 89bio, Inc. (ETNB) | Chief Medical Officer | Sell | 352,656 | $0 |
| 2025-08-05 | 89bio, Inc. (ETNB) | Chief Medical Officer | Sell | 7,680 | $70,349 |
| 2025-06-13 | 89bio, Inc. (ETNB) | Chief Medical Officer | Sell | 8,498 | $81,751 |
| 2025-02-19 | 89bio, Inc. (ETNB) | Chief Medical Officer | Sell | 1,050 | $11,098 |
| 2025-02-11 | 89bio, Inc. (ETNB) | Chief Medical Officer | Sell | 3,817 | $43,552 |
| 2025-02-04 | 89bio, Inc. (ETNB) | Chief Medical Officer | Buy | 80,000 | $0 |
| 2025-02-04 | 89bio, Inc. (ETNB) | Chief Medical Officer | Sell | 3,338 | $32,045 |
Source: SEC Form 4 filings · as of 2025-10-30